Jane Street’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.01M | Buy |
+276,875
| New | +$3.74M | ﹤0.01% | 4035 |
|
|
2026
Q1 | – | Sell |
-569,353
| Closed | -$7.99M | – | 12748 |
|
|
2025
Q4 | $7.99M | Sell |
569,353
-611,102
| -52% | -$8.57M | ﹤0.01% | 2604 |
|
|
2025
Q3 | $16.5M | Buy |
1,180,455
+181,111
| +18% | +$2.61M | ﹤0.01% | 1843 |
|
|
2025
Q2 | $15M | Sell |
999,344
-775,795
| -44% | -$11.1M | ﹤0.01% | 1724 |
|
|
2025
Q1 | $23.4M | Buy |
1,775,139
+226,446
| +15% | +$3.12M | 0.01% | 1182 |
|
|
2024
Q4 | $24.5M | Buy |
1,548,693
+587,748
| +61% | +$8.83M | 0.01% | 1126 |
|
|
2024
Q3 | $15.3M | Sell |
960,945
-498,100
| -34% | -$8.02M | ﹤0.01% | 1479 |
|
|
2024
Q2 | $22.2M | Buy |
1,459,045
+893,205
| +158% | +$12.8M | 0.01% | 1228 |
|
|
2024
Q1 | $8.3M | Buy |
565,840
+541,215
| +2,198% | +$7.9M | ﹤0.01% | 2008 |
|
|
2023
Q4 | $343K | Sell |
24,625
-9,545
| -28% | -$128K | ﹤0.01% | 7415 |
|
|
2023
Q3 | $457K | Sell |
34,170
-1,017,995
| -97% | -$13.8M | ﹤0.01% | 6430 |
|
|
2023
Q2 | $13.3M | Buy |
1,052,165
+1,027,395
| +4,148% | +$12M | ﹤0.01% | 1611 |
|
|
2023
Q1 | $282K | Sell |
24,770
-3,280
| -12% | -$35.4K | ﹤0.01% | 7299 |
|
|
2022
Q4 | $290K | Sell |
28,050
-51,370
| -65% | -$554K | ﹤0.01% | 7074 |
|
|
2022
Q3 | $831K | Buy |
+79,420
| New | +$846K | ﹤0.01% | 5757 |
|
|
2022
Q2 | – | Sell |
-25,665
| Closed | -$286K | – | 10657 |
|
|
2022
Q1 | $286K | Buy |
+25,665
| New | +$291K | ﹤0.01% | 8469 |
|
|
2021
Q3 | – | Sell |
-15,845
| Closed | -$211K | – | 10584 |
|
|
2021
Q2 | $233K | Buy |
+15,845
| New | +$222K | ﹤0.01% | 8585 |
|
|
2020
Q4 | – | Sell |
-31,185
| Closed | -$434K | – | 8002 |
|
|
2020
Q3 | $434K | Buy |
31,185
+11,155
| +56% | +$133K | ﹤0.01% | 5369 |
|
|
2020
Q2 | $212K | Buy |
+20,030
| New | +$204K | ﹤0.01% | 6302 |
|
|
2019
Q4 | – | Sell |
-26,445
| Closed | -$200K | – | 5621 |
|
|
2019
Q3 | $200K | Sell |
26,445
-11,765
| -31% | -$87.5K | ﹤0.01% | 4649 |
|
|
2019
Q2 | $283K | Buy |
+38,210
| New | +$300K | ﹤0.01% | 4274 |
|
|
2018
Q4 | – | Sell |
-85,050
| Closed | -$589K | – | 5564 |
|
|
2018
Q3 | $589K | Sell |
85,050
-587,590
| -87% | -$3.93M | ﹤0.01% | 3420 |
|
|
2018
Q2 | $4.33M | Buy |
+672,640
| New | +$4.24M | 0.01% | 1171 |
|
|
2018
Q1 | – | Sell |
-261,400
| Closed | -$1.96M | – | 5301 |
|
|
2017
Q4 | $1.96M | Sell |
261,400
-263,095
| -50% | -$1.89M | 0.01% | 1619 |
|
|
2017
Q3 | $3.74M | Buy |
+524,495
| New | +$3.77M | 0.01% | 1086 |
|
|
2017
Q2 | – | Sell |
-192,395
| Closed | -$1.54M | – | 4775 |
|
|
2017
Q1 | $1.54M | Buy |
+192,395
| New | +$1.66M | 0.01% | 1605 |
|
|
2016
Q4 | – | Sell |
-447,770
| Closed | -$4.16M | – | 4515 |
|
|
2016
Q3 | $4.16M | Buy |
+447,770
| New | +$4.27M | 0.02% | 694 |
|
|
2016
Q2 | – | Sell |
-417,410
| Closed | -$3.77M | – | 4497 |
|
|
2016
Q1 | $3.77M | Sell |
417,410
-625,620
| -60% | -$5.59M | 0.02% | 717 |
|
|
2015
Q4 | $9.66M | Buy |
1,043,030
+273,135
| +35% | +$2.99M | 0.06% | 275 |
|
|
2015
Q3 | $9.84M | Buy |
769,895
+581,700
| +309% | +$7.23M | 0.06% | 264 |
|
|
2015
Q2 | $2.08M | Buy |
188,195
+160,000
| +567% | +$1.77M | 0.01% | 983 |
|
|
2015
Q1 | $322K | Sell |
28,195
-266,855
| -90% | -$2.83M | ﹤0.01% | 2454 |
|
|
2014
Q4 | $2.98M | Buy |
+295,050
| New | +$3.11M | 0.02% | 505 |
|
|
2014
Q3 | – | Sell |
-330,590
| Closed | -$2.85M | – | 2963 |
|
|
2014
Q2 | $2.85M | Buy |
+330,590
| New | +$2.78M | 0.04% | 405 |
|
|
2014
Q1 | – | Sell |
-109,805
| Closed | -$901K | – | 2995 |
|
|
2013
Q4 | $901K | Sell |
109,805
-1,230,285
| -92% | -$9.74M | 0.01% | 841 |
|
|
2013
Q3 | $10.1M | Buy |
1,340,090
+1,279,695
| +2,119% | +$9.31M | 0.12% | 128 |
|
|
2013
Q2 | $457K | Buy |
+60,395
| New | +$441K | 0.01% | 1529 |
|
Other funds holding RDY
AIM
Jane Street's RDY Position: Q2 2026 in Review
Jane Street opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 276,875 shares worth $4.01M. The stake represents ﹤0.01% of the portfolio and ranks #4035 among its holdings. This is a return to the name: Jane Street previously reported a position in RDY as recently as Q4 2025.
Jane Street first reported a position in RDY in Q2 2013 and has held it in 37 quarters since. The position peaked at $24.5M in Q4 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Jane Street held 276,875 shares of Dr. Reddy's Laboratories worth $4.01M as of Q2 2026.
- Dr. Reddy's Laboratories was a new Jane Street position in Q2 2026.
- Dr. Reddy's Laboratories made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4035 holding.
- Jane Street first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 37 quarters since.
- Jane Street's Dr. Reddy's Laboratories position peaked at $24.5M in Q4 2024.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.